Women's perspectives on impact on the post menopause of use of the 52 mg levonorgestrel intrauterine device during the menopausal transition

Autor(es)

Versailles, Jacques B. E. ; Metelus, Sherly ; Peloggia, Alessandra ; Laporte, Montas ; Bahamondes, Luis ; Juliato, Cassia

• Tipo de documento: Artigo Científico
• Fonte: EUROPEAN JOURNAL OF CONTRACEPTION AND REPRODUCTIVE HEALTH CARE; v. 28, n. 4, p. 3-pg., 2023-05-27.

Resumo

Objectives: To assess perimenopausal users of 52mg levonorgestrel intrauterine devices (LNG-IUD) regarding the IUD impact after menopause. Material and methods: a cross-sectional study with users aged 40 and 49 years old, without cognitive impairment that answered a questionnaire regarding worries and benefits after the menopause due to LNG-IUD use. Results: Almost half of 221 users (52.9%) have concerns that LNG-IUD use could influence aspects after menopause, 111 (50.3%) that the post-menopause symptoms get worse and 92 (41.6%) that interfere with recognition of menopausal symptoms. Conclusion: Half of perimenopausal LNG-IUD users expressed concerns about how device use could affect post-menopause symptoms. SHORT CONDENSATION The 52mg hormonal-IUD who were at menopausal transition reported worries that the use of the IUD can affect menopausal symptoms. It is important that health professionals can routinely guide these women. (AU)

• Processo FAPESP: 15/20504-9 - Manifestações clínicas de usuárias de contraceptivos de somente progestogênios
• Beneficiário: Luis Guillermo Bahamondes
• Modalidade de apoio: Auxílio à Pesquisa - Temático